Clinical Trials Logo

Hyperphagia clinical trials

View clinical trials related to Hyperphagia.

Filter by:

NCT ID: NCT03341247 Completed - Pediatric Obesity Clinical Trials

Brain Mechanisms of Overeating in Children

RO1
Start date: January 31, 2018
Phase:
Study type: Observational

The proposed research will follow healthy weight children who vary by family risk for obesity to identify the neurobiological and appetitive traits that are implicated in overeating and weight gain during the critical pre-adolescent period. The investigator's central hypothesis is that increased intake from large portions of energy dense foods is due in part to reduced activity in brain regions implicated in inhibitory control and decision making, combined with increased activity in reward processing pathways. To test this hypothesis, the investigators will recruit 120 healthy weight children, aged 7-8 years, at two levels of obesity risk (i.e., 60 high-risk and 60 low-risk) based on parent weight status. This will result in 240 participants: 120 children and their parents.

NCT ID: NCT03184389 Completed - Smoking Cessation Clinical Trials

Sense2Stop:Mobile Sensor Data to Knowledge

Start date: June 23, 2017
Phase: N/A
Study type: Interventional

The aim of this research is to build systems that can recognize when people are stressed and then provide them with relaxation prompts in the moment to reduce their likelihood of being stressed, smoking, or overeating in the near future. Using these systems should help smokers be more effective in their attempts to quit by reducing their tendency to lapse when they are stressed or experiencing other negative moods or behaviors.

NCT ID: NCT03007368 Completed - Clinical trials for Obesity and Other Hyperalimentation

Digestion of Foods Consumed in Africa

Start date: March 2012
Phase: N/A
Study type: Interventional

As populations become urbanized in Africa, the change to a more Westernized diet has been associated with rise in obesity and related metabolic syndrome diseases. The current study shows that in the West African Sahel, these replacement starchy staple foods have fast gastric emptying compared to traditional sorghum and millet foods; and implies that the latter could be beneficial in lowering glycemic response, providing energy from a meal over a longer time, and providing a satiety effect. Knowledge of this attribute of sorghum and millet foods could be useful to improve their image in West African cities to increase their consumption and to improve markets for local smallholder farmers.

NCT ID: NCT02936076 Completed - Obesity Clinical Trials

Exercise as a Buffer Against Stress-induced Overeating

Start date: January 16, 2017
Phase: N/A
Study type: Interventional

The purpose of this study is to examine the psychological benefits of chronic exercise as well as the effects of exercise training on eating behaviors and stress-induced overeating in overweight and obese women. Participants will be randomized to an 12-week exercise condition or a delayed exercise condition. Assessments will occur at baseline, 6 weeks, and 12 weeks and will include answering surveys in real-time using smartphones, several assessments of eating behaviors and dietary intake, and questionnaire measures of factors which could mediate the relationship between exercise and eating. Participants will be compensated for completing assessments and for adherence to the exercise protocol.

NCT ID: NCT02701738 Completed - Healthy Clinical Trials

Impact of Exercise on the Metabolic Consequences of Overeating

XO
Start date: January 12, 2016
Phase: N/A
Study type: Interventional

The primary purpose of this study is to examine the effects of 1-week of overeating on important clinical metabolic health outcomes (e.g., glucose tolerance, blood lipid profile, and blood pressure) and factors regulating the structure and metabolic function of fat tissue. This study will determine how regular exercise during this overeating period impacts these responses.

NCT ID: NCT02629991 Completed - Clinical trials for Prader-Willi Syndrome

Oxytocin vs. Placebo for the Treatment Hyperphagia in Children and Adolescents With Prader-Willi Syndrome

OXT-PWS
Start date: October 2015
Phase: Phase 2
Study type: Interventional

The investigators propose a randomized double-blind 8 week treatment trial of intranasal oxytocin (IN-OXT) vs. placebo in 24 subjects aged 5 to 18 years with PWS in order to assess IN-OXT's affect on (1) Eating behaviors (2) Repetitive and disruptive behaviors and (3) Salivary OXT levels.

NCT ID: NCT02467036 Completed - Obesity Clinical Trials

Family Based Treatment for Weight Loss With Breakfast Prescription

FAB
Start date: January 2014
Phase: N/A
Study type: Interventional

The purpose of this study is to evaluate whether a behavioral weight loss group in conjunction with a prescribed breakfast can help children between 8 and 12 years of age change their behaviors to help them lose weight and become healthier.

NCT ID: NCT02368379 Completed - Clinical trials for Adrenal Insufficiency

Diagnosis of Central Adrenal Insufficiency in Patients With Prader-Willi Syndrome

Start date: March 2014
Phase: N/A
Study type: Interventional

The purpose of this study is to determine presence of central adrenal insufficiency in children with Prader Willi Syndrome using low dose (1 mcg) ACTH stimulation test compared to results of overnight metyrapone test.

NCT ID: NCT02013258 Completed - Clinical trials for Prader Willi Syndrome

Oxytocin Trial in Prader-Willi Syndrome

Start date: March 2015
Phase: Phase 1
Study type: Interventional

Individuals with Prader-Willi syndrome (PWS) have been found to have a deficit of oxytocin-producing neurons and decreased oxytocin receptor gene function, so the purpose of this study is to determine if oxytocin (OT) administration will improve some of the aspects of Prader-Willi syndrome that are particularly troublesome for children and their families (the insatiable appetite and social behaviors). The research questions are: 1. Does intranasal oxytocin cause any side effects in children with PWS? 2. Does intranasal oxytocin administration alter appetite or behaviors in PWS?

NCT ID: NCT01976455 Completed - Obesity Clinical Trials

The Breathe Light Study

Start date: October 2013
Phase:
Study type: Observational

The purpose of this study is to develop a novel, non-invasive method that will provide personalized feedback during dietary interventions as a marker for compliance.